133 related articles for article (PubMed ID: 7310805)
21. Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7.
Matsoukas JM; Agelis G; Hondrelis J; Yamdagni R; Wu Q; Ganter R; Smith JR; Moore D; Moore GJ
J Med Chem; 1993 Apr; 36(7):904-11. PubMed ID: 8464045
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
Goghari MH; Franklin KJ; Moore GJ
J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological properties of [1-N4-dimethyl-asparagine]-angiotensin II.
Cordopatis P; Brison J; Dirkx J; Theodoropoulos D
Experientia; 1979 Jul; 35(7):849-50. PubMed ID: 477828
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and pharmacology of a prohormone angiotensin antagonist.
Chiu AT; Sutherland JC; Day AR; Freer RJ
Eur J Pharmacol; 1979 Feb; 54(1-2):177-80. PubMed ID: 421740
[TBL] [Abstract][Full Text] [Related]
25. Derivatives of melphalan designed to enhance drug accumulation in cancer cells.
Kupczyk-Subotkowska L; Tamura K; Pal D; Sakaeda T; Siahaan TJ; Stella VJ; Borchardt RT
J Drug Target; 1997; 4(6):359-70. PubMed ID: 9239576
[TBL] [Abstract][Full Text] [Related]
26. Studies on position 1 of angiotensin II: effects on affinity and duration of action from alkyl amide substitution.
Cordopatis P; Theodoropoulos D; Guillemette G; Escher E
J Med Chem; 1981 Feb; 24(2):209-11. PubMed ID: 7205889
[TBL] [Abstract][Full Text] [Related]
27. Novel synthesis of cyclic amide-linked analogues of angiotensins II and III.
Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore GJ
J Med Chem; 1994 Sep; 37(18):2958-69. PubMed ID: 8071943
[TBL] [Abstract][Full Text] [Related]
28. [Synthesis and analysis of cyclic analogs of angiotensin].
Antsans IuE; Bisenietse DA; Vosekalna IA; Myshliakova NV; Chipens GI
Bioorg Khim; 1990 Mar; 16(3):358-69. PubMed ID: 2357239
[TBL] [Abstract][Full Text] [Related]
29. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N,N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro.
Efthimiou M; Andrianopoulos C; Stephanou G; Demopoulos NA; Nikolaropoulos SS
Mutat Res; 2007 Apr; 617(1-2):125-37. PubMed ID: 17324445
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of angiotensin II antagonists by incorporating alpha-methylalanine or O-methylthreonine residues in angiotension II analogues.
Khosla MC; Muñoz-Ramírez H; Hall MM; Khairallah PA; Bumpus FM
J Med Chem; 1977 Aug; 20(8):1051-5. PubMed ID: 894674
[No Abstract] [Full Text] [Related]
31. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
[No Abstract] [Full Text] [Related]
33. Role of the C-terminal carboxylate in angiotensin II activity: alcohol, ketone, and ester analogues of angiotensin II.
Hsieh KH; Marshall GR
J Med Chem; 1986 Oct; 29(10):1968-71. PubMed ID: 3761315
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II analogues. 14. Roles of the imidazole nitrogens of position-6 histidine in pressor activity.
Hsieh KH; Jorgensen EC; Lee TC
J Med Chem; 1979 Oct; 22(10):1199-206. PubMed ID: 513068
[No Abstract] [Full Text] [Related]
35. AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics.
Johannesson P; Erdélyi M; Lindeberg G; Frändberg PA; Nyberg F; Karlén A; Hallberg A
J Med Chem; 2004 Nov; 47(24):6009-19. PubMed ID: 15537355
[TBL] [Abstract][Full Text] [Related]
36. Development and activities of a new melphalan prodrug designed for tumor-selective activation.
Kerr DE; Li Z; Siemers NO; Senter PD; Vrudhula VM
Bioconjug Chem; 1998; 9(2):255-9. PubMed ID: 9548542
[TBL] [Abstract][Full Text] [Related]
37. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
Moore G; Oudeman E; Gorman P
Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
[No Abstract] [Full Text] [Related]
38. A cyclic angiotensin antagonist: [1,8-cysteine]angiotensin II.
Matsoukas JM; Scanlon MN; Moore GJ
J Med Chem; 1984 Mar; 27(3):404-6. PubMed ID: 6699887
[TBL] [Abstract][Full Text] [Related]
39. Modulation of membrane transport of alkylating agents and amino acids by an analog of vasopressin in murine L5178Y lymphoblasts in vitro.
Miller L; Kobrinsky NL; Goldenberg GJ
Biochem Pharmacol; 1987 Jan; 36(1):169-76. PubMed ID: 3801052
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues.
Stachowiak K; Khosla MC; Plucinska K; Khairallah PA; Bumpus FM
J Med Chem; 1979 Sep; 22(9):1128-30. PubMed ID: 490561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
